21

Lepu Biopharma Co LtdHKG 2157 Stock Report

Last reporting period 30 Jun, 2023

Updated 19 Sep, 2024

Last price

Market cap $B

0.688

Micro

Exchange

XHKG - Hong Kong Exchange

View Section: Financials

Lepu Statements

21

Lepu Income Statement

B

M

CNY (except Earnings per share)

Financial

Revenue

Cost of sales

Gross profit

Research and development

Selling, general and administrative

Total operating expenses

Operating income

Interest expense

Other income

Income before tax

Provision for income taxes

Net income

Diluted earnings per share

Shares outstanding after dilution

2023-06-30
%

153.55

5.755

147.8

231.87

52.934

265.79

-118

-23.261

-0.648

-141.9

-141.9

-0.086

1 659.44

2022-12-31
%

15.572

100

2.005

12.9

13.567

87.1

293.58

1885.3

55.936

359.2

347.37

2230.7

-333.8

-2143.6

-16.57

-106.4

-0.692

-4.4

-351.07

-2254.5

0

-344.77

-2214.01

-0.208

1 659.75

2022-06-30
%

100

0

0

230.71

0

84.783

0

371.46

0

-371.46

0

22.967

0

-0.488

0

-348.37

0

0

-344.29

0

-0.212

1 621.9

2021-12-31
%

100

0

0

378.54

0

78.306

0

494.13

0

-494.13

0

-17.062

0

-0.325

0

-506.15

0

0

-499.04

0

-0.297

1 677.58

2021-06-30
%

100

0

0

412.67

0

77.755

0

522.43

0

-522.43

0

-0.293

0

0

-522.72

0

0

-511.95

0

-0.305

1 677.58

View Section: Balance Sheet